Trials / Completed
CompletedNCT01531049
Smoking Habits and Smoking Cessation in Young Adults
Smoking Cessation in Young Adults in Northern Finland
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- Tuula Toljamo · Academic / Other
- Sex
- All
- Age
- 18 Years – 26 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the efficacy and effectiveness of varenicline and nicotine patch combined with motivational interview technique in smoking cessation of young adults over 12 months follow-up.
Detailed description
Most teenage smokers are still smoking when they become adults confirming that stopping of smoking at young age is difficult although majority of young smokers want to quit. Young smokers experience many relapses partly due to the lack of appropriate and available cessation services. The discomfort experienced during cessation attempts is likely to be negatively associated with cessation success. Quitting of smoking is by the far most important procedure in preventing COPD progression. In Finland, 18-35% of young adults smoke, the variability being associated at least with socioeconomic background, education and geographical area. Our recent studies on male military draftees have shown that smoking is much more frequent in Northern than Southern Finland. However young men want to quit and accept new smoking restrictions. Very few studies are available on quitting attempts or counselling, pharmacotherapy and/or their combinations in young adults who want to quit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | varenicline | days 1.-3 0,5mgx1/day, days 4.-7 0,5mgx2/day, day 8 to the 12weeks 1mgx2 /day |
| DRUG | Nicotine cutaneous patch 15mg/16h | One patch for 16hours/day and duration of 8 weeks. |
| DRUG | Nicotine cutaneous patch 10mg/16h | One patch 16hours/day and duration of 8 weeks |
| OTHER | Placebo cutaneous patch | No active medication.O ne patch 16hours and duration for 8 weeks |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2015-12-31
- Completion
- 2016-09-02
- First posted
- 2012-02-10
- Last updated
- 2017-06-05
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT01531049. Inclusion in this directory is not an endorsement.